Abbvie Inc. vs Stryker Corporation
ABBV vs SYK — side-by-side comparison from reported financials. ABBV leads 5, SYK leads 6 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Stryker Corporation
SYK · Healthcare
$277.70+0.26%Mixed
| Metric | ABBV | SYK |
|---|---|---|
| Price | $276.43 | $277.70 |
| Market cap | $488B | $107B |
| Revenue (TTM) | $64.4B | $25.8B |
| Revenue growth | +1.8% | +10.8% |
| Net margin | 9.8% | 14.4% |
| Free cash flow | $18.2B | $4.70B |
| Net cash (debt) | ($56.2B) | ($11.8B) |
| 1-year price return | +19.8% | -25.0% |
| P/E | 77.4 | 28.5 |
| P/E vs own history (cheap-side %) | 23% | 99% |
| Dividend yield | 2.45% | 1.24% |
| Return on equity | 96% | 16% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 56,000 |
Full résumé-style profiles: ABBV CV · SYK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.